CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide

Por Bidstrup, Tanja Busk, Bjørnsdottir, Inga, Sidelmann, Ulla Grove, Thomsen, Mikael Søndergård, Hansen, Kristian Tage
Publicado em 2003

Body of evidence and approaches applied in the clinical development programme of fixed‐dose combinations in the European Union from 2010 to 2016

Por Nøhr‐Nielsen, Asbjørn, De Bruin, Marie Louise, Thomsen, Mikael, Pipper, Christian Bressen, Lange, Theis, Bjerrum, Ole Jannik, Lund, Trine Meldgaard
Publicado no Br J Clin Pharmacol (2019)